Interactions of spin-labeled calmodulin with trifluoperazine and phosphodiesterase in the presence of Ca(II), Cd(II), La(III), Tb(III), and Lu(III).
Bovine calmodulin analogues, spin-labeled at methionine and tyrosine residues, have been utilized in electron paramagnetic resonance (EPR) studies designed to investigate calmodulin interactions with the antipsychotic drug trifluoperazine and the calmodulin-binding protein 3',5'-cyclic nucleotide phosphodiesterase. Trifluoperazine titrations of spin-labeled calmodulin analogues were carried out in the presence of Ca(II), Cd(II), and Tb(III). Similar experiments were performed with the phosphodiesterase in the presence of Ca(II), Cd(II), La(III), Tb(III), and Lu(III). EPR signals from the methionine-directed probe proved to be more sensitive to the binding of target molecules than signals from the tyrosine-directed probe, perhaps indicating that the spin-labeled methionine is at a site close to the target molecule binding site. While the binding of TFP, as monitored by EPR spectral changes in the methionine spin-labeled calmodulin, was in evidence with Ca(II), Cd(II), and all the lanthanides examined, no binding of phosphodiesterase to calmodulin could be detected in the presence of the lanthanide ions, perhaps due to inactivation of the phosphodiesterase by lanthanide ion binding. The abilities of the spin-labeled calmodulins to activate phosphodiesterase were also investigated. The spin-labeled tyrosine calmodulin was able to activate phosphodiesterase as well as native calmodulin, while a lower degree of activation was found when the spin-labeled methionine analogue was used.
Buccigross
J M
JM
Department of Chemistry, College of Mt. St. Joseph, Ohio.
Nelson
D J
DJ
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000378:metabolism*; D002104:Cadmium / Q000494:pharmacology*; D002118:Calcium / Q000494:pharmacology*; D002147:Calmodulin / Q000378:metabolism*; D004578:Electron Spin Resonance Spectroscopy; D007811:Lanthanum / Q000494:pharmacology; D008187:Lutetium / Q000494:pharmacology; D008674:Metals, Rare Earth / Q000494:pharmacology*; D011485:Protein Binding; D013113:Spin Labels; D013725:Terbium / Q000494:pharmacology; D014268:Trifluoperazine / Q000378:metabolism*
D002147:Calmodulin; D008674:Metals, Rare Earth; D013113:Spin Labels; D002104:Cadmium; D013725:Terbium; D014268:Trifluoperazine; D008187:Lutetium; D007811:Lanthanum; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D002118:Calcium